Synthesis and Distribution of Drugs of Abuse and Related Compounds

The National Institute on Drug Abuse (NIDA) within the NIH is issuing a Sources‑Sought notice to identify small‑business vendors capable of synthesizing, labeling, storing, and distributing controlled and non‑controlled drug compounds for research purposes. Respondents must demonstrate DEA research registration (Schedules II‑V) and the ability to obtain registration for Schedule I substances, along with facilities for secure, refrigerated storage of large‑quantity chemical inventories. Submissions are limited to a single 10‑page capability statement (excluding cover page, executive summary, resumes, and references) and must be submitted electronically by the deadline. • Provide capability statements showing DEA registration, experience with radiolabeled (tritium, 14C, 125I, deuterium) and unlabeled drug synthesis, and secure storage/handling of controlled substances. • Must meet purity standards (≥ 95 %) and offer analysis, testing, and data‑sheet generation for the drug inventory. • Submission format: Microsoft Word or PDF, 11‑12 pt font, 8½×11 in., 1‑in. margins, single/double spaced; one copy required; no paper or fax submissions accepted. • Deadline for electronic submission: 1:00 PM EST, 20 Nov 2026; subject line must include the Sources‑Sought number, UEI, and organization name.